Curaleaf Executive Chairman of the Board Boris Jordan Says Co Supplies 50% Of Medical Market In New York
Portfolio Pulse from Benzinga Newsdesk
Curaleaf's Executive Chairman, Boris Jordan, stated that the company supplies 50% of the medical market in New York. The information was shared during a Benzinga subscriber event.
September 28, 2023 | 6:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Curaleaf, a significant holding in the AdvisorShares Pure US Cannabis ETF (MSOS), announced it supplies 50% of the medical market in New York.
Curaleaf's dominance in the New York medical market could potentially boost its performance, which in turn may positively impact the MSOS ETF, given that Curaleaf is a significant holding in this fund.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 75